2[3]Martha Mitch Funnell. Robert M. Anderson. The problem with compliance in diabetes. JAMA ,2000,284 ( 13 ): 1709. 被引量：1
3[6]Tebbi CK. Treatment compliance in childhood and adolescence. Cancer, 1993,71:3441. 被引量：1
4[7]Vaur L, Vaisse B, Genes N, et al. Use of electronic pill boxes to assess risk of poor treatment compliance: results of a large - scale trial. Am J Hypertens, 1999,12 (4 Pt 1 ): 374-380. 被引量：1
5[8]Andrejak M,Genes N,Vaur L,et al. Electronic pill boxes in the evaluation of antihypertensive treatment compliance:Comparison of once daily versus twice daily regimen. Am J Hypertens,2000,13 (2) :184-190. 被引量：1
6[9]Van Berge Henegouwen MT. Van Driel HF. Kasteleijn Nolst Trenite DG. A patient diary as a tool to improve medicine compliance. PharmWorldSci. 1999, 21 (1): 21 -24. 被引量：1
7[10]Spooren D,Van Heeringen C,Jannes C. Strategies to increase compliance with outpatient aftercare among patients referred to a psychiatric emergency department: a multicentre controlled intervention study.Psychol Med, 1998,28 (4) :949 - 956. 被引量：1
5Elena Salmoirago-Blotcher,ra S Ockene.Methodological limitations of psychosocial interventions in patients with an implantable cardioverter-defibrillator (ICD):A systematic review.BMC Cardiovasc Disord,2009,:56-61. 被引量：1
6Vellone E,ega ML,alletti C,t al.Quality of life in people with pacemaker.Prof Inferm,2008,1(4):235-244. 被引量：1
7Kamath PK.Pacemaker follow up guidelines for physicians.J Assoc Physicians India,2007,5(Suppl):66-70. 被引量：1
